Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5984574 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL5985367 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL2367356 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL5985370 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL2367294 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL294865 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL5984140 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL5986484 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL5986344 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL739205 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2690085-B1 | NORBORNENE-ESTER-BASED DERIVATIVE, METHOD FOR PREPARING SAME, AND USES THEREOF | UNIV SANGMYUNG SEOUL INDUSTRY ACADEMY COOPERATION FOUNDATION (KR) | 2016-01-20 | — | — | EP | claimed |
| US-20150152039-A1 | NORBORNENE-ESTER-BASED DERIVATIVE, METHOD FOR PREPARING SAME, AND USES THEREOF | SANGMYUNG UNIVERSITY SEOUL INDUSTRY-ACADEMY COOPERATION FOUNDATION (KR) | 2015-06-04 | — | — | US | claimed |
| EP-2690085-A2 | NORBORNENE-ESTER-BASED DERIVATIVE, METHOD FOR PREPARING SAME, AND USES THEREOF | Sangmyung University Seoul Industry-Academy Cooperation Foundation (KR) | 2014-01-29 | — | — | EP | claimed |
| US-20140018568-A1 | NORBORNENE-ESTER-BASED DERIVATIVE, METHOD FOR PREPARING SAME, AND USES THEREOF | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2014-01-16 | — | — | US | claimed |
| EP-1711106-A2 | INTERFACE FOR USE BETWEEN MEDICAL INSTRUMENTATION AND A PATIENT | Therus Corporation (US) | 2006-10-18 | — | — | EP | claimed |
| US-20050215901-A1 | Interface for use between medical instrumentation and a patient | OTSUKA MEDICAL DEVICES CO., LTD. (JP) | 2005-09-29 | — | — | US | claimed |
| WO-2005072616-A2 | INTERFACE FOR USE BETWEEN MEDICAL INSTRUMENTATION AND A PATIENT | THERUS CORPORATION (US) | 2005-08-11 | — | — | WO | claimed |
| WO-2024111129-A1 | METHOD FOR PRODUCING POLYIMIDE PRECURSOR, POLYIMIDE PRECURSOR, PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING PATTERN CURED PRODUCT, AND ELECTRONIC COMPONENT | ＨＤマイクロシステムズ株式会社 | 2024-05-30 | — | — | WO | disclosed |
| WO-2024111422-A1 | HYDROGEN SILANE COMPOSITION AND METHOD OR PRODUCING HYDROSILYLATION REACTANT | 信越化学工業株式会社 | 2024-05-30 | — | — | WO | disclosed |
| WO-2024111130-A1 | POLYAMIC ACID ESTER AND RESIN COMPOSITION | ＨＤマイクロシステムズ株式会社 | 2024-05-30 | — | — | WO | disclosed |
| WO-2024111131-A1 | POLYAMIC ACID ESTER AND RESIN COMPOSITION | ＨＤマイクロシステムズ株式会社 | 2024-05-30 | — | — | WO | disclosed |
| WO-2024099911-A1 | IRON CARBONYL COMPLEXES WITH CHIRAL, BIDENTATE BIPHOSPHINE LIGANDS | BASF SE (DE) | 2024-05-16 | — | — | WO | disclosed |
| WO-2024095573-A1 | POLYIMIDE PRECURSOR AND RESIN COMPOSITION | ＨＤマイクロシステムズ株式会社 | 2024-05-10 | — | — | WO | disclosed |
| US-6201087-B1 | POLYMERS WHICH CONTAIN COUMARIN OR QUINOLINONE DERIVATIVES AS PHOTOREACTIVE UNITS AS ORIENTING LAYERS FOR LIQUID CRYSTALS; PHOTOCHEMICAL STABILITY AND IMPROVED CONTRAST | ROLIC AG (CH) | 2001-03-13 | — | — | US | disclosed |
| EP-0421441-B1 | Pantothenic acid derivatives | FUJIREBIO KK (JP) | 1995-01-25 | — | — | EP | disclosed |
| US-5120738-A | Cardiovascular disorders | FUJIREBIO INC. (JP) | 1992-06-09 | — | — | US | disclosed |
| EP-0212989-B1 | LIPID VESICLES CONTAINING LABELED SPECIES AND THEIR ANALYTICAL USES | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1992-02-19 | — | — | EP | disclosed |
| EP-0421441-A2 | Pantothenic acid derivatives | FUJIREBIO INC. (JP) | 1991-04-10 | — | — | EP | disclosed |
| US-4752572-A | Lipid vesicles containing labeled species and their analytical uses | EASTMAN KODAK COMPANY (US) | 1988-06-21 | — | — | US | disclosed |
| US-4301080-A | DYES ALSO CONTAINING A PHENYLALKYLAMINO GROUP | CIBA-GEIGY CORPORATION (US) | 1981-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150152039-A1 | NORBORNENE-ESTER-BASED DERIVATIVE, METHOD FOR PREPARING SAME, AND USES THEREOF | NOTUM, UGT1A8, CYP19A1 | TRPV1 3804/4885TRPA1 3114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.